Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I Study.
Li W, Xiong A, Yang N, Fan H, Yu Q, Zhao Y, Wang Y, Meng X, Wu J, Wang Z, Liu Y, Wang X, Qin X, Lu K, Zhuang W, Ren Y, Zhang X, Yan B, Lovly CM, Zhou C.
Li W, et al. Among authors: yan b.
J Clin Oncol. 2024 Jun 1:JCO2400731. doi: 10.1200/JCO.24.00731. Online ahead of print.
J Clin Oncol. 2024.
PMID: 38822758